Aggregated α‐synuclein activates microglia: a process leading to disease progression in Parkinson's disease

Free radicals in biology and medicine

Gutteridge, J. M. C. (1991) · General Pharmacology The Vascular System · doi:10.1016/0306-3623(91)90478-o · Cited by 17,178

Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids

Green, L. C., Wagner, D. A., Glogowski, J. A., Skipper, P. L., Wishnok, J. S., & Tannenbaum, S. R. (1982) · Analytical Biochemistry · doi:10.1016/0003-2697(82)90118-x · Cited by 12,061

Free Radicals in Biology and Medicine

Halliwell, B., & Gutteridge, J. M. C. (2015) · doi:10.1093/acprof:oso/9780198717478.001.0001 · Cited by 8,990

Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease

Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., et al. (1997) · Science · doi:10.1126/science.276.5321.2045 · Cited by 8,240

α-Synuclein Locus Triplication Causes Parkinson's Disease

Singleton, A. B., Farrer, M., Johnson, J., Singleton, A., Hague, S., Kachergus, J., Hulihan, M., Peuralinna, T., Dutra, A., Nussbaum, R., et al. (2003) · Science · doi:10.1126/science.1090278 · Cited by 4,383

AlaSOPro mutation in the gene encoding α-synuclein in Parkinson's disease

Krüger, R., Kuhn, W., Müller, T., Woitalla, D., Graeber, M., Kösel, S., Przuntek, H., Epplen, J. T., Schols, L., & Riess, O. (1998) · Nature Genetics · doi:10.1038/ng0298-106 · Cited by 3,836

Reactive microglia are positive for HLA‐DR in the substantia nigra of Parkinson's and Alzheimer's disease brains

McGeer, P. L., Itagaki, S., Boyes, B. E., & McGeer, E. G. (1988) · Neurology · doi:10.1212/wnl.38.8.1285 · Cited by 2,990

The new mutation, E46K, of α‐synuclein causes parkinson and Lewy body dementia

Zarranz, J. J., Alegre, J., Gómez‐Esteban, J. C., Lezcano, E., Ros, R., Ampuero, I., Vidal, L., Hoenicka, J., Rodriguez, O., Atarés, B., et al. (2004) · Annals of Neurology · doi:10.1002/ana.10795 · Cited by 2,737

NADPH Oxidase: An Update

BABIOR, B. M. (1999) · Blood · doi:10.1182/blood.v93.5.1464 · Cited by 2,147

Mice Lacking α-Synuclein Display Functional Deficits in the Nigrostriatal Dopamine System

Abeliovich, A., Schmitz, Y., Fariñas, I., Choi-Lundberg, D., Ho, W.-H., Castillo, P. E., Shinsky, N., Verdugo, J. M. G., Armanini, M., Ryan, A., et al. (2000) · Neuron · doi:10.1016/s0896-6273(00)80886-7 · Cited by 1,722

Elevated Hapln2 Expression Contributes to Protein Aggregation and Neurodegeneration in an Animal Model of Parkinson's Disease

Wang, Q., Zhou, Q., Zhang, S., Shao, W., Yin, Y., Li, Y., Hou, J., Zhang, X., Guo, Y.-S., Wang, X., et al. (2016) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2016.00197 · Cited by 21

When safeguarding goes wrong: Impact of oxidative stress on protein homeostasis in health and neurodegenerative disorders

Mesika, R., & Reichmann, D. (2018) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2018.11.001 · Cited by 20

Brain organoid models for studying the function of iPSC-derived microglia in neurodegeneration and brain tumours

Sabogal-Guáqueta, A. M., Mitchell-Garcia, T., Hunneman, J., Voshart, D. C., Thiruvalluvan, A., Foijer, F., Kruyt, F. A. E., Trombetta-Lima, M., Eggen, B. J. L., Boddeke, E., et al. (2024) · Neurobiology of Disease · doi:10.1016/j.nbd.2024.106742 · Cited by 19

Biomimetic Nanoparticles Enhance Recovery of Movement Disorders in Parkinson’s Disease by Improving Microglial Mitochondrial Homeostasis and Suppressing Neuroinflammation

Li, L., Sun, C., Cai, S., Hang, Z., Gao, X., Hou, L., Li, L., Wu, Y., Xing, C., & Du, H. (2025) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.4c22181 · Cited by 19

Current Progress in the Development of Probes for Targeting α-Synuclein Aggregates

Zeng, Q., & Cui, M. (2022) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.1c00877 · Cited by 19

Immunogenetic Determinants of Parkinson’s Disease Etiology

Kung, P., Elsayed, I., Reyes‐Pérez, P., & Bandrés‐Ciga, S. (2022) · Journal of Parkinson s Disease · doi:10.3233/jpd-223176 · Cited by 22

The role of α-synuclein in neurodegeneration — An update

Jellinger, K. A. (2012) · Translational Neuroscience · doi:10.2478/s13380-012-0013-1 · Cited by 19

A note on testing hypotheses for stationary processes in the frequency domain

Holger Dette, A., & Hildebrandt, T. (2011) · Journal of Multivariate Analysis · doi:10.1016/j.jmva.2011.07.002 · Cited by 19

Stimulations of the Culture Medium of Activated Microglia and TNF-Alpha on a Scrapie-Infected Cell Line Decrease the Cell Viability and Induce Marked Necroptosis That Also Occurs in the Brains from the Patients of Human Prion Diseases

Ma, Y., Shi, Q., Xiao, K., Wang, J., Chen, C., Gao, L., Gao, C., & Dong, X. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00354 · Cited by 20

Molecular Imaging of Striatal Dopaminergic Neuronal Loss and the Neurovascular Unit in Parkinson Disease

Ivanidze, J., Skafida, M., Pandya, S., Patel, D., Osborne, J. R., Raj, A., Gupta, A. K., Henchcliffe, C., & Dyke, J. P. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.528809 · Cited by 18

Harnessing the immune system for the treatment of Parkinson’s disease

Vedam‐Mai, V. (2021) · Brain Research · doi:10.1016/j.brainres.2021.147308 · Cited by 20

Resistance of naturally secreted α‐synuclein to proteolysis

Ximerakis, M., Pampalakis, G., Roumeliotis, T. I., Sykioti, V. S., Garbis, S. D., Stefanis, L., Sotiropoulou, G., & Vekrellis, K. (2014) · The FASEB Journal · doi:10.1096/fj.13-245852 · Cited by 20

Neuronal RING finger protein 11 (RNF11) regulates canonical NF-κB signaling

Pranski, E. L., Dalal, N. V., Herskowitz, J. H., Orr, A. L., Roesch, L. A., Fritz, J. J., Heilman, C. J., Lah, J. J., Levey, A. I., & Betarbet, R. S. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-67 · Cited by 19

Towards New Therapies for Parkinson's Disease

Finkelstein, D. I. (2011) · InTech eBooks · doi:10.5772/954 · Cited by 19

Literature-Related Discovery (LRD)

Kostoff, R. N., Block, J. A., Solka, J. L., Briggs, M. B., Rushenberg, R. L., Stump, J. A., Johnson, D., Lyons, T. J., & Wyatt, J. R. (2007) · Defense Technical Information Center (DTIC) · doi:10.21236/ada473438 · Cited by 19

Immune cell metabolic dysfunction in Parkinson’s disease

Mark, J. R., & Tansey, M. G. (2025) · Molecular Neurodegeneration · doi:10.1186/s13024-025-00827-y · Cited by 25

Evaluation of Microglia/Macrophage Cells from Rat Striatum and Prefrontal Cortex Reveals Differential Expression of Inflammatory-Related mRNA after Methamphetamine

Kays, J. S., & Yamamoto, B. K. (2019) · Brain Sciences · doi:10.3390/brainsci9120340 · Cited by 18

Dual Roles of Microglia in the Basal Ganglia in Parkinson’s Disease

Choudhury, M. E., Kigami, Y., & Tanaka, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22083907 · Cited by 18

Leukotriene Signaling as a Target in α-Synucleinopathies

Strempfl, K., Unger, M. S., Flunkert, S., Trost, A., Reitsamer, H. A., Hutter‐Paier, B., & Aigner, L. (2022) · Biomolecules · doi:10.3390/biom12030346 · Cited by 17

EGCG has Dual and Opposing Effects on the N-terminal Region of Self-associating α-synuclein Oligomers

Grønnemose, A. L., Østerlund, E. C., Otzen, D. E., & Jørgensen, T. J. D. (2022) · Journal of Molecular Biology · doi:10.1016/j.jmb.2022.167855 · Cited by 18

Potential for Therapeutic-Loaded Exosomes to Ameliorate the Pathogenic Effects of α-Synuclein in Parkinson’s Disease

Rademacher, D. J. (2023) · Biomedicines · doi:10.3390/biomedicines11041187 · Cited by 18

Increased tyrosine hydroxylase expression accompanied by glial changes within the non-lesioned hemisphere in the 6-hydroxydopamine model of Parkinson's disease

Schlachetzki, J. C. M., Marxreiter, F., Regensburger, M., Kulinich, A. O., Winner, B., & Winkler, J. (2014) · Restorative Neurology and Neuroscience · doi:10.3233/rnn-130371 · Cited by 19

Isolation and functional analysis of yeast ubiquitin ligase Rsp5 variants that alleviate the toxicity of human α-synuclein

Wijayanti, I., Watanabe, D., Oshiro, S., & Takagi, H. (2014) · The Journal of Biochemistry · doi:10.1093/jb/mvu069 · Cited by 17

The critical role of Nramp1 in degrading α-synuclein oligomers in microglia under iron overload condition

Wu, K.-C., Liou, H., Kao, Y.-H., Lee, C.-Y., & Lin, C. (2017) · Neurobiology of Disease · doi:10.1016/j.nbd.2017.05.001 · Cited by 17

Down‐regulation of natural resistance‐associated macrophage protein‐1 (Nramp1) is associated with 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine (MPTP)/1‐methyl‐4‐phenylpyridinium (MPP+)‐induced α‐synuclein accumulation and neurotoxicity

Wu, K., Liou, H., Lee, C.-Y., & Lin, C. (2018) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12493 · Cited by 18

Current experimental disease-modifying therapeutics for multiple system atrophy

Lemos, M., Wenning, G. K., & Stefanova, N. (2021) · Journal of Neural Transmission · doi:10.1007/s00702-021-02406-z · Cited by 17

A single intranigral administration of β-sitosterol β-d-glucoside elicits bilateral sensorimotor and non-motor alterations in the rat

Soto-Rojas, L. O., Garcés‐Ramírez, L., Luna-Herrera, C., Flores-Martinez, Y. M., Soto-Rodríguez, G., Gatica-García, B., López-Salas, F. E., Ayala-Dávila, J., Gutiérrez-Castillo, M. E., Padilla-Viveros, A., et al. (2019) · Behavioural Brain Research · doi:10.1016/j.bbr.2019.112279 · Cited by 18

Emerging roles of leptin in Parkinson’s disease: Chronic inflammation, neuroprotection and more?

Regensburger, M., Rasul Chaudhry, S., Yasin, H., Zhao, Y., Stadlbauer, A., Buchfelder, M., & Kinfe, T. (2023) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2022.09.010 · Cited by 17

Effects of exercise on neuroinflammation in age-related neurodegenerative disorders

Su, Y., & Su, Z. (2025) · European journal of medical research · doi:10.1186/s40001-025-03165-3 · Cited by 22

Imaging neuroinflammation in Alzheimer’s and other dementias: recent advances and future directions

Brooks, D. J. (2016) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2016.01.049 · Cited by 17

Identification of Shared Genes Between Ischemic Stroke and Parkinson's Disease Using Genome-Wide Association Studies

Lang, W., Wang, J., Ma, X., Zhang, N., Li, H., Cui, P., & Hao, J. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.00297 · Cited by 16

Memantine exerts neuroprotective effects by modulating α-synuclein transmission in a parkinsonian model

Lee, J. E., Kim, H., Kim, D.-Y., Shin, Y. J., Shin, J. Y., & Lee, P. H. (2021) · Experimental Neurology · doi:10.1016/j.expneurol.2021.113810 · Cited by 17

Gut instincts in neuroimmunity from the eighteenth to twenty-first centuries

Nguyen, M. T., & Palm, N. W. (2022) · Seminars in Immunopathology · doi:10.1007/s00281-022-00948-2 · Cited by 21

Spreading of alpha-synuclein between different cell types

Ruf, W. P., Meirelles, J. L., & Danzer, K. M. (2022) · Behavioural Brain Research · doi:10.1016/j.bbr.2022.114059 · Cited by 19

Pathological mechanisms of neuroimmune response and multitarget disease-modifying therapies of mesenchymal stem cells in Parkinson’s disease

Zhuo, Y., Li, X., He, Z., & Lu, M. (2023) · Stem Cell Research & Therapy · doi:10.1186/s13287-023-03280-0 · Cited by 17

Crosstalk between SIRT1/Nrf2 signaling and NLRP3 inflammasome/pyroptosis as a mechanistic approach for the neuroprotective effect of linagliptin in Parkinson’s disease

Ghaith, W. Z., Wadie, W., & El-Yamany, M. F. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.113716 · Cited by 19

α-Synuclein potentiates interleukin-1β-induced CXCL10 expression in human A172 astrocytoma cells

Tousi, N. S., Buck, D. J., Curtis, J. T., & Davis, R. L. (2011) · Neuroscience Letters · doi:10.1016/j.neulet.2011.12.001 · Cited by 17

Neuroinflammation as a therapeutic target in neurodegenerative diseases

Gordon, R., & Woodruff, T. M. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-805120-7.00003-8 · Cited by 19

Modulation of Innate Immunity by Amyloidogenic Peptides

Westwell-Roper, C. Y., & Verchere, C. B. (2019) · Trends in Immunology · doi:10.1016/j.it.2019.06.005 · Cited by 17

Extracellular microvesicles-derived from microglia treated with unaggregated α-synuclein attenuate mitochondrial fission and toxicity-induced by Parkinsonian toxin MPP+

Li, N., Wu, Y., Zhu, L., Huang, Y. X. R., Liu, Z., Shi, M. Y., Soltys, D., Zhang, J., & Chang, Q. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.07.084 · Cited by 17

Recurrent systemic infections with Streptococcus pneumoniae do not aggravate the course of experimental neurodegenerative diseases

Ebert, S., Goos, M., Rollwagen, L., Baake, D., Zech, W., Esselmann, H., Wiltfang, J., Mollenhauer, B., Schliebs, R., Gerber, J., et al. (2009) · Journal of Neuroscience Research · doi:10.1002/jnr.22270 · Cited by 17

Oxidative stress in a rat model of chronic gliosis

Bates, K. A., Martins, R. N., & Harvey, A. R. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.05.003 · Cited by 18

Potential Use of Nanomedicine for the Anti-inflammatory Treatment of Neurodegenerative Diseases

Otero, M. D. C., Espinosa‐Oliva, A. M., Herrera, A. J., García-Domínguez, I., Arévalo, M. F., Martín‐Banderas, L., & de Pablos, R. M. (2018) · Current Pharmaceutical Design · doi:10.2174/1381612824666180403113015 · Cited by 17

MicroRNAs Modulating Neuroinflammation in Parkinson's disease

Saadh, M. J., Muhammad, F. A., Singh, A., Mustafa, M. A., Zuhairi, R. A. H. A., Ghildiyal, P., Hashim, G. M., Alsaikhan, F., Khalilollah, S., & Akhavan‐Sigari, R. (2024) · Inflammation · doi:10.1007/s10753-024-02125-z · Cited by 16

Mapping of catecholaminergic denervation, neurodegeneration, and inflammation in 6-OHDA-treated Parkinson’s disease mice

Santoro, M., Lam, R. K., Blumenfeld, S. E., Tan, W., Ciari, P., Chu, E. K., Saw, N. L., Rijsketic, D. R., Lin, J. S., Heifets, B. D., et al. (2025) · npj Parkinson s Disease · doi:10.1038/s41531-025-00872-w · Cited by 16

p21-activated kinase 4 controls the aggregation of α-synuclein by reducing the monomeric and aggregated forms of α-synuclein: involvement of the E3 ubiquitin ligase NEDD4-1

Won, S.-Y., Park, J., You, S.-T., Hyeun, J.-A., Kim, H. K., Jin, B. K., McLean, C., Shin, E., & Kim, E. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-05030-1 · Cited by 18

Clinical biomarkers for Lewy body diseases

Abdelmoaty, M. M., Lu, E., Kadry, R., Foster, E. G., Bhattarai, S., Mosley, R. L., & Gendelman, H. E. (2023) · Cell & Bioscience · doi:10.1186/s13578-023-01152-x · Cited by 17

Microglia Process α‐Synuclein Fibrils and Enhance their Pathogenicity in a TREM2‐Dependent Manner

Xiong, M., Xia, D., Yu, H., Meng, L., Zhang, X., Chen, J., Tian, Y., Yuan, X., Niu, X., Nie, S., et al. (2024) · Advanced Science · doi:10.1002/advs.202413451 · Cited by 21

Associations of Matrix Metalloproteinase-9 and Tissue Inhibitory Factor-1 Polymorphisms With Parkinson Disease in Taiwan

Chen, Y., Wu, Y., Mesri, M., & Chen, C. (2016) · Medicine · doi:10.1097/md.0000000000002672 · Cited by 19

The Immunopathogenesis of Neuroinvasive Lesions of SARS-CoV-2 Infection in COVID-19 Patients

Alipoor, S. D., Mortaz, E., Varahram, M., Garssen, J., & Adcock, I. M. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2021.697079 · Cited by 16

Demystifying the Neuroprotective Role of Neuropeptides in Parkinson’s Disease: A Newfangled and Eloquent Therapeutic Perspective

Behl, T., Madaan, P., Sehgal, A., Singh, S., Makeen, H. A., Albratty, M., Alhazmi, H. A., Meraya, A. M., & BUNGAU, S. G. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23094565 · Cited by 19

Modulatory effects of sodium salicylate on the factors affecting protein aggregation during rotenone induced Parkinson’s disease pathology

Thakur, P. S., & Nehru, B. (2014) · Neurochemistry International · doi:10.1016/j.neuint.2014.05.002 · Cited by 16

Prion-like propagation of α-synuclein in the gut-brain axis

Chen, Y., Shao, Q.-H., Yuan, Y., & Chen, N. (2018) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2018.06.002 · Cited by 15

Design, synthesis and identification of N, N-dibenzylcinnamamide (DBC) derivatives as novel ligands for α-synuclein fibrils by SPR evaluation system

Chen, Y.-F., Bian, J., Zhang, P., Bu, L.-L., Shen, Y., Yu, W., Lu, X., Lin, X., Ye, D., Wang, J., et al. (2020) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2020.115358 · Cited by 16

Alpha-synuclein decreases arachidonic acid incorporation into rat striatal synaptoneurosomes.

Adamczyk, A., Kacprzak, M. D., & Kaźmierczak, A. (2007) · PubMed · Cited by 16

The Intranigral Infusion of Human-Alpha Synuclein Oligomers Induces a Cognitive Impairment in Rats Associated with Changes in Neuronal Firing and Neuroinflammation in the Anterior Cingulate Cortex

Palmas, M. F., Etzi, M., Pisanu, A., Camoglio, C., Sagheddu, C., Santoni, M., Manchinu, M. F., Pala, M., Fusco, G., Simone, A. D., et al. (2022) · Cells · doi:10.3390/cells11172628 · Cited by 15

The reduction of astrocytic tau prevents amyloid-β-induced synaptotoxicity

Cisternas, P., Taylor, X., Martínez, P., Maldonado, O., Jury, N., & Lasagna‐Reeves, C. A. (2022) · Brain Communications · doi:10.1093/braincomms/fcac235 · Cited by 15

Loss of cannabinoid receptor 2 promotes α-Synuclein-induced microglial synaptic pruning in nucleus accumbens by modulating the pCREB-c-Fos signaling pathway and complement system

Feng, L., Lo, H., You, H., Wu, W., Cheng, X., Xin, J., Ye, Z., Chen, X., & Pan, X. (2022) · Experimental Neurology · doi:10.1016/j.expneurol.2022.114230 · Cited by 15

TIPE2 regulates the response of BV2 cells to lipopolysaccharide by the crosstalk between PI3K/AKT signaling and microglia M1/M2 polarization

Gao, J., Wang, N., Zong, F., Dong, J., Lin, Y., Zhang, H., & Zhang, F. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.110389 · Cited by 15

Protein network exploration prioritizes targets for modulating neuroinflammation in Parkinson’s disease

Bonte, M.-A., Idrissi, F. E., Gressier, B., Devos, D., & Bélarbi, K. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.107526 · Cited by 17

Pathology of Neurodegenerative Diseases

Kim, Y. S., Kim, Y.-K., Hwang, O., & Dong, J. (2012) · InTech eBooks · doi:10.5772/38028 · Cited by 16

Mitochondrial Respiration in Intact Peripheral Blood Mononuclear Cells and Sirtuin 3 Activity in Patients with Movement Disorders

Michalak, S., Florczak‐Wyspianska, J., Rybacka-Mossakowska, J., Ambrosius, W., Osztynowicz, K., Baszczuk, A., Kozubski, W. P., & Wysocka, E. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/9703574 · Cited by 15

Cerebrospinal fluid from patients with multiple system atrophy promotes in vitro α-synuclein fibril formation

Hirohata, M., Ono, K., Morinaga, A., Ikeda, T., & Yamada, M. (2011) · Neuroscience Letters · doi:10.1016/j.neulet.2011.01.005 · Cited by 15

Alpha-synuclein and cortico-striatal plasticity in animal models of Parkinson disease

Marino, G., Calabresi, P., & Ghiglieri, V. (2022) · Handbook of clinical neurology · doi:10.1016/b978-0-12-819410-2.00008-4 · Cited by 15

Time-Course of Alterations in the Endocannabinoid System after Viral-Mediated Overexpression of α-Synuclein in the Rat Brain

Kelly, R. L., Bemelmans, A., Joséphine, C., Brouillet, E., McKernan, D. P., & Dowd, E. (2022) · Molecules · doi:10.3390/molecules27020507 · Cited by 14

In vitro models of multiple system atrophy from primary cells to induced pluripotent stem cells

Abati, E., Fonzo, A. D., & Corti, S. P. (2018) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13563 · Cited by 14

Neuroprotective effect of diclofenac on chlorpromazine induced catalepsy in rats

Naeem, S., Najam, R., Khan, S. S., Mirza, T., & Sikandar, B. (2019) · Metabolic Brain Disease · doi:10.1007/s11011-019-00416-1 · Cited by 14

Mesenchymal stem cells modulate misfolded α-synuclein in parkinsonian disorders: A multitarget disease-modifying strategy

Shin, J. Y., & Lee, P. H. (2020) · Stem Cell Research · doi:10.1016/j.scr.2020.101908 · Cited by 15

Potential roles of functional bacterial amyloid proteins, bacterial biosurfactants and other putative gut microbiota products in the etiopathogeny of Parkinson’s Disease

Manole, E., Dumitrescu, L., Niculite, C. M., Popescu, B. O., & Ceafalan, L. C. (2021) · Biocell · doi:10.32604/biocell.2021.013452 · Cited by 14

A New Insight into an Alternative Therapeutic Approach to Restore Redox Homeostasis and Functional Mitochondria in Neurodegenerative Diseases

Hyun, D., & Lee, J. (2021) · Antioxidants · doi:10.3390/antiox11010007 · Cited by 15

GBA1 and The Immune System: A Potential Role in Parkinson’s Disease?

Al‐Azzawi, Z. A. M., Arfaie, S., & Gan‐Or, Z. (2022) · Journal of Parkinson s Disease · doi:10.3233/jpd-223423 · Cited by 16

Hydrogels for brain repair: application to Parkinson’s disease

Campo-Montoya, R. D., Luquín, M. R., Puerta, E., Garbayo, E., & Blanco‐Prieto, M. J. (2022) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2022.2136161 · Cited by 14

Unaltered SNARE complex formation in an in vivo model of prion disease

Asuni, A. A., Cunningham, C. M., Vigneswaran, P., Perry, V. H., & O'Connor, V. M. (2008) · Brain Research · doi:10.1016/j.brainres.2008.07.083 · Cited by 14

More than a Rumor Spreads in Parkinson's Disease

Prymaczok, N. C., Riek, R., & Gerez, J. (2016) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2016.00608 · Cited by 15

The implication of neuronimmunoendocrine (NIE) modulatory network in the pathophysiologic process of Parkinson’s disease

Shen, Y., Guo, X., Han, C., Wan, F. J., Ma, K., Guo, S., Wang, L., Xia, Y. F., Liu, L., Lin, Z., et al. (2017) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2549-2 · Cited by 15

The Healing Effect of Human Milk Fat Globule-EGF Factor 8 Protein (MFG-E8) in A Rat Model of Parkinson’s Disease

Nakashima, Y., Miyagi‐Shiohira, C., Noguchi, H., & Ōmasa, T. (2018) · Brain Sciences · doi:10.3390/brainsci8090167 · Cited by 14

Apoptosis signal regulating kinase 1 deletion mitigates α-synuclein pre-formed fibril propagation in mice

Zhang, J., Park, E. S., Park, H.-J., Yan, R., Grudniewska, M., Zhang, X., Oh, S. E., Yang, X., Baum, J., & Mouradian, M. M. (2019) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2019.09.012 · Cited by 14

The Role of Free Radicals in the Nervous System

Friedman, J. H. (2010) · Humana Press eBooks · doi:10.1007/978-1-60327-514-9_1 · Cited by 14

α-Synuclein condensation in synaptic vesicle function and synucleinopathies

Li, D., Liu, K., Li, D., Brünger, A. T., Liu, C., Burré, J., & Diao, J. (2025) · Trends in Cell Biology · doi:10.1016/j.tcb.2025.03.007 · Cited by 13

Inhibition of α-synuclein aggregation by MT101-5 is neuroprotective in mouse models of Parkinson’s disease

Kim, S., Choi, J. G., Kim, S. W., Park, S. C., Kang, Y.-R., Park, D. S., Son, M., & Lee, C. H. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113637 · Cited by 13

Neuroanatomical and cognitive biomarkers of alpha‐synuclein propagation in a mouse model of synucleinopathy prior to onset of motor symptoms

Tullo, S., de Miranda, A. S., del Cid‐Pellitero, E., Lim, M. P., Gallino, D., Attaran, A., Patel, R., Novikov, V., Park, M., Beraldo, F. H., et al. (2023) · Journal of Neurochemistry · doi:10.1111/jnc.15967 · Cited by 17

Allopregnanolone and its antagonist modulate neuroinflammation and neurological impairment

Bäckström, T. C., Doverskog, M., Blackburn, T. P., Scharschmidt, B. F., & Felipo, V. (2024) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2024.105668 · Cited by 14

Positron Emission Tomography with [18F]ROStrace Reveals Progressive Elevations in Oxidative Stress in a Mouse Model of Alpha-Synucleinopathy

Gallagher, E. P., Hou, C., Zhu, Y., Hsieh, C., Lee, H. S., Li, S., Xu, K., Henderson, P., Chroneos, R., Sheldon, M., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25094943 · Cited by 15

Cre‐dependent AAV vectors for highly targeted expression of disease‐related proteins and neurodegeneration in the substantia nigra

Grames, M. S., Dayton, R. D., Jackson, K. L., Richard, A. D., Lu, X., & Klein, R. L. (2018) · The FASEB Journal · doi:10.1096/fj.201701529rr · Cited by 12

Nobiletin attenuates inflammation via modulating proinflammatory and antiinflammatory cytokine expressions in an autoimmune encephalomyelitis mouse model

Yarım, G. F., Yarım, M., Sözmen, M., Gökçeoğlu, A., Ertekin, A., Kabak, Y. B., & Karaca, E. (2021) · Fitoterapia · doi:10.1016/j.fitote.2021.105099 · Cited by 14

Neuroinflammation in early, late and recovery stages in a progressive parkinsonism model in rats

Cunha, D. M. G., Becegato, M. S., Meurer, Y. D. S. R., Lima, A. C., Gonçalves, N., Bioni, V. S., Engi, S. A., Bianchi, P., Cruz, F. C., dos Santos, J. R., et al. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.923957 · Cited by 14

Dysregulation of Circulatory Levels of lncRNAs in Parkinson’s Disease

Huang, T., Zhao, J.-Y., Pan, R., Jiang, T., Fu, X., Huang, Q. M., Wang, X., Gong, P., Tian, Y., & Zhang, Y. (2022) · Molecular Neurobiology · doi:10.1007/s12035-022-03086-w · Cited by 13

Role of Telomeres and Telomerase in Parkinson's Disease—A New Theranostics?

Vellingiri, B., Balasubramani, K., Iyer, M., Raj, N., Elangovan, A., Song, K., Yeo, H. C., Jayakumar, N., Kinoshita, M., Ravimanickam, T., et al. (2023) · Advanced Biology · doi:10.1002/adbi.202300097 · Cited by 14

The Therapeutic Potential of LRRK2 and α-Synuclein in Parkinson's Disease

Sen, S., & West, A. B. (2009) · Antioxidants and Redox Signaling · doi:10.1089/ars.2009.2430 · Cited by 12

The role of NADPH oxidase (NOX) enzymes in neurodegenerative disease

Ajayi, A., Yu, X., & Ström, A. (2012) · Frontiers in Biology · doi:10.1007/s11515-012-1250-y · Cited by 12

Effect of naturally occurring α-synuclein-antibodies on toxic α-synuclein-fragments

Rabenstein, M., Agbo, D. B., Wolf, E., Dams, J., Nicolai, M., Roeder, A., Bacher, M., Dodel, R. C., & Noelker, C. (2019) · Neuroscience Letters · doi:10.1016/j.neulet.2019.04.004 · Cited by 13

A single-nucleotide polymorphism of the osteopontin gene may contribute to a susceptibility to Lewy body disease

Maetzler, W., Michelis, J., Tomiuk, J., Melms, A., Becker, C., Gasser, T., Schulte, C., & Berg, D. (2009) · Journal of Neural Transmission · doi:10.1007/s00702-009-0209-x · Cited by 13

Natural products targeting cellular processes common in Parkinson's disease and multiple sclerosis

Xu, X., Han, C., Wang, P., & Zhou, F. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1149963 · Cited by 12

An LRP1-binding motif in cellular prion protein replicates cell-signaling activities of the full-length protein

Mantuano, E., Zampieri, C., Azmoon, P., Gunner, C. B., Heye, K. R., & Gonias, S. L. (2023) · JCI Insight · doi:10.1172/jci.insight.170121 · Cited by 12

Neuroprotective Effects of Bromelain on the Common Neurodegenerative Diseases: A Systematic Review

Rostamian, S., Raeisi, E., Heidari-Soureshjani, S., & Sherwin, C. M. T. (2023) · Neurochemical Journal · doi:10.1134/s1819712423040256 · Cited by 13

Uptake of alpha‐synuclein preformed fibrils is suppressed by inflammation and induces an aberrant phenotype in human microglia

Niskanen, J., Peltonen, S., Ohtonen, S., Fazaludeen, M. F., Luk, K. C., Giudice, L., Koıstınaho, J., Malm, T., Goldsteins, G., Albert, K., et al. (2024) · Glia · doi:10.1002/glia.24626 · Cited by 16

Early-start vs delayed-start donepezil against cognitive decline in Parkinson disease: a randomized clinical trial

Sawada, H., Oeda, T., Kohsaka, M., Tomita, S., Umemura, A., Park, K., Yamamoto, K., & Kiyohara, K. (2020) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2020.1814255 · Cited by 12

GM1 ganglioside modifies microglial and neuroinflammatory responses to α-synuclein in the rat AAV-A53T α-synuclein model of Parkinson's disease

Schneider, J. S., Singh, G., Williams, C. K., & Singh, V. (2022) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2022.103729 · Cited by 11

[18F]NOS PET Brain Imaging Suggests Elevated Neuroinflammation in Idiopathic Parkinson’s Disease

Doot, R. K., Young, A. J., Nasrallah, I. M., Wetherill, R. R., Siderowf, A. D., Mach, R. H., & Dubroff, J. G. (2022) · Cells · doi:10.3390/cells11193081 · Cited by 12

GM1 oligosaccharide efficacy against α-synuclein aggregation and toxicity in vitro

Fazzari, M., Biase, E. D., Zaccagnini, L., Henriques, A., Callizot, N., Ciampa, M. G., Mauri, L., Carsana, E. V., Loberto, N., Aureli, M., et al. (2023) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2023.159350 · Cited by 12

The FASEB Journal • Research Communication Aggregated -synuclein activates microglia: a process leading to disease progression in Parkinson’s disease

Zhang, W., Wang, T., Pei, Z., Miller, D. S., Wu, X., & Zhang, J. (2016)

Pathological α-synuclein exacerbates the progression of Parkinson’s disease through microglial activation

Zhang, Q.-S., Heng, Y., Yuan, Y.-H., & Chen, N.-H. (2017) · Toxicology Letters · doi:10.1016/j.toxlet.2016.11.002 · Cited by 156

Extracellular α-synuclein – a possible initiator of inflammation in Parkinson's disease

Ren, W., Zeng-min, T., Yin, F., Sun, J.-Z., & Zhang, J. (2016) · Die Pharmazie · doi:10.31083/ph.2016.5070 · Cited by 3

Nitrated alpha‐synuclein‐activated microglial profiling for Parkinson’s disease

Reynolds, A. D., Glanzer, J. G., Kadiu, I., Ricardo-Dukelow, M., Chaudhuri, A., Ciborowski, P. S., Cerny, R. L., Gelman, B. B., Thomas, M. P., Mosley, R. L., et al. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.05087.x · Cited by 247

doi: 10.3389/fnins.2011.00080

Béraud, D., Twomey, M. A., Bloom, B., Mittereder, A., Ton, V., Neitzke, K., Chasovskikh, S., Mhyre, T. R., Maguire-zeiss, K. A., Stanilova, S. A., et al. (2011)